4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org


BioGenerator News

$100 million Confluence deal is good exit for BioGenerator

May 24, 2018

Following Pfizer’s announcement to cut 600 of its 1,000 St. Louis-area jobs in 2009, several Pfizer executives, including Joe Monahan and Walter Smith, faced a difficult decision. They could relocate […]

Read More

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Venture Capital Financing for Canopy Biosciences

May 22, 2018

Startup to Advance Research Tools Development and Add Jobs ST. LOUIS – Canopy Biosciences has exceeded its Series A financing goal, closing a $2.4 million investment to develop new research […]

Read More

BacterioScan, a BioGenerator portfolio company, secures FDA clearance – UTI detection in hours, not days

May 14, 2018

St. Louis, May 14, 2018 – BacterioScan, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract […]

Read More

BioGenerator Company RNAgri Inks Deal with Monsanto for Use of RNA Production Technology

Apr 04, 2018

BioGenerator-backed AgTech Company Focuses on Naturally-Occurring Process ST. LOUIS – RNAgri, a St. Louis startup developing technology for agriculture, has entered a research collaboration with global agriculture company Monsanto. The […]

Read More

St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company

Feb 19, 2018

BioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from […]

Read More

SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Cardiac Hologram Research

Feb 12, 2018

ST. LOUIS – A panel of cardiologists, engineers, and other experts have given SentiAR, Inc.’s augmented reality (AR) platform an exceptional peer review, leading the National Institutes for Health (NIH) […]

Read More

BioGenerator Wins Federal Grant to Build New St. Louis Bioscience Companies

Sep 26, 2017

ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is […]

Read More

BioGenerator supported startup Disarm Therapeutics announces $30M financing

Sep 19, 2017

BioGenerator supported startup company Disarm Therapeutics has closed a $30M financing led by top tier venture funds including Atlas Ventures. Prior to the company being formed, BioGenerator supported the academic […]

Read More

BioGenerator Company Cofactor Genomics Announces $18M Series-A Round to Bring RNA to Precision Medicine

Sep 18, 2017

SAN FRANCISCO — Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing […]

Read More

BioGenerator Co-Leads Seed Round for Washington University Company SentiAR

Sep 12, 2017

ST. LOUIS – SentiAR, Inc. has closed a $1.1M Seed Round to accelerate its work to revolutionize the operating room with augmented reality software designed to improve visualization in cardiac […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors